Cargando…

A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting

OBJECTIVE: We report a case in which transient cerebral vasospasm after carotid artery stenting (CAS) was effectively treated using arterial and intravenous infusion of fasudil hydrochloride, but cerebral hyperperfusion syndrome (CHS) developed during subsequent treatment. CASE PRESENTATION: The pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashina, Motoshige, Sato, Yohei, Noda, Mariko, Sasakawa, Mayu, Thamamongood, Thiparpa, Hashizume, Akihiro, Ogishima, Takahiro, Tamaki, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Neuroendovascular Therapy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370509/
https://www.ncbi.nlm.nih.gov/pubmed/37502349
http://dx.doi.org/10.5797/jnet.cr.2022-0065
_version_ 1785077948392407040
author Yamashina, Motoshige
Sato, Yohei
Noda, Mariko
Sasakawa, Mayu
Thamamongood, Thiparpa
Hashizume, Akihiro
Ogishima, Takahiro
Tamaki, Masashi
author_facet Yamashina, Motoshige
Sato, Yohei
Noda, Mariko
Sasakawa, Mayu
Thamamongood, Thiparpa
Hashizume, Akihiro
Ogishima, Takahiro
Tamaki, Masashi
author_sort Yamashina, Motoshige
collection PubMed
description OBJECTIVE: We report a case in which transient cerebral vasospasm after carotid artery stenting (CAS) was effectively treated using arterial and intravenous infusion of fasudil hydrochloride, but cerebral hyperperfusion syndrome (CHS) developed during subsequent treatment. CASE PRESENTATION: The patient was a 79-year-old man who underwent right CAS to treat symptomatic right carotid artery stenosis. After the procedure, the patient developed left paresis and unilateral spatial neglect. The following day, he developed diffuse cerebral vasospasm in the right middle cerebral artery that improved immediately upon arterial infusion of fasudil hydrochloride. Intravenous infusion of fasudil hydrochloride was then started, but CHS with epileptic seizures developed after 1 day of treatment. After 23 days of medical treatment, the condition of the patient improved to mild hemiparesis. CONCLUSION: The present case suggests that transient cerebral vasospasm after CAS may turn into CHS during treatment and that continuous monitoring for cerebral perfusion is important.
format Online
Article
Text
id pubmed-10370509
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Japanese Society for Neuroendovascular Therapy
record_format MEDLINE/PubMed
spelling pubmed-103705092023-07-27 A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting Yamashina, Motoshige Sato, Yohei Noda, Mariko Sasakawa, Mayu Thamamongood, Thiparpa Hashizume, Akihiro Ogishima, Takahiro Tamaki, Masashi J Neuroendovasc Ther Case Report OBJECTIVE: We report a case in which transient cerebral vasospasm after carotid artery stenting (CAS) was effectively treated using arterial and intravenous infusion of fasudil hydrochloride, but cerebral hyperperfusion syndrome (CHS) developed during subsequent treatment. CASE PRESENTATION: The patient was a 79-year-old man who underwent right CAS to treat symptomatic right carotid artery stenosis. After the procedure, the patient developed left paresis and unilateral spatial neglect. The following day, he developed diffuse cerebral vasospasm in the right middle cerebral artery that improved immediately upon arterial infusion of fasudil hydrochloride. Intravenous infusion of fasudil hydrochloride was then started, but CHS with epileptic seizures developed after 1 day of treatment. After 23 days of medical treatment, the condition of the patient improved to mild hemiparesis. CONCLUSION: The present case suggests that transient cerebral vasospasm after CAS may turn into CHS during treatment and that continuous monitoring for cerebral perfusion is important. The Japanese Society for Neuroendovascular Therapy 2023-01-14 2023 /pmc/articles/PMC10370509/ /pubmed/37502349 http://dx.doi.org/10.5797/jnet.cr.2022-0065 Text en ©2023 The Japanese Society for Neuroendovascular Therapy https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives International License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Case Report
Yamashina, Motoshige
Sato, Yohei
Noda, Mariko
Sasakawa, Mayu
Thamamongood, Thiparpa
Hashizume, Akihiro
Ogishima, Takahiro
Tamaki, Masashi
A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting
title A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting
title_full A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting
title_fullStr A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting
title_full_unstemmed A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting
title_short A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting
title_sort case of cerebral hyperperfusion syndrome during treatment of transient cerebral vasospasm following carotid artery stenting
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370509/
https://www.ncbi.nlm.nih.gov/pubmed/37502349
http://dx.doi.org/10.5797/jnet.cr.2022-0065
work_keys_str_mv AT yamashinamotoshige acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT satoyohei acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT nodamariko acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT sasakawamayu acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT thamamongoodthiparpa acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT hashizumeakihiro acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT ogishimatakahiro acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT tamakimasashi acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT yamashinamotoshige caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT satoyohei caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT nodamariko caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT sasakawamayu caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT thamamongoodthiparpa caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT hashizumeakihiro caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT ogishimatakahiro caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting
AT tamakimasashi caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting